Webinar

Virtual Roundtable: U.S. Tobacco Control: Addressing Racial Disparities

Wednesday, October 26, 2022
Speakers
Brian A. King

Director, Center for Tobacco Products, U.S. Food and Drug Administration

Jennifer Lee

Director, Bureau of Tobacco Control, New York State Department of Health

Presider
Thomas J. Bollyky

Senior Fellow for Global Health, Economics, and Development and Director of the Global Health Program, Council on Foreign Relations

Global Health Program

Significant developments in tobacco control are on the horizon in the United States. This year, the U.S. Food and Drug Administration proposed bans on menthol cigarettes and flavored cigars and suggested regulations restricting nicotine content in tobacco products. These U.S. policies could have profound implications for public health and racial equity and could set a new international standard for nicotine content regulation for other nations to follow.  Our speakers, Dr. Brian A. King from the Center for Tobacco Products at the U.S. Food and Drug Administration, and Dr. Jennifer Lee from the Department of Tobacco Control at the New York State Department of Health, discuss the proposed U.S. regulations and their potential implications for public health and racial equity in the United States and abroad.

Explore More on United States

United States

How the U.S. Asylum Process Works
Asylum has become a central part of the U.S. immigration debate in recent years after border crossings reached a record high in fiscal year 2023. Here’s how the asylum process works.

Backgrounder by Diana Roy February 19, 2025

Trade

What Are Tariffs?
President Donald Trump has begun his second term with a raft of tariff threats to bolster his immigration priorities, support local industries, and compete with China. Here’s how these taxes work and how they’ve been used historically.  

Backgrounder by Anshu Siripurapu and Noah Berman February 3, 2025 Renewing America

Health

What Is the FDA’s Role in Public Health?
The U.S. health agency regulates the country’s foods and drugs, among other products. With the FDA’s role in drug development and nutrition policy and its COVID-19 pandemic response driving controversy, President Donald Trump is set to shake up its leadership.  

Backgrounder by Mariel Ferragamo and Claire Klobucista January 27, 2025

Top Stories on CFR

Ecuador

Ecuador’s Next President Will Face Debt, Drought, and Gangs
April’s runoff election could decide whether Ecuador continues a descent into instability and violence, or charts a new course.

Expert Brief by Will Freeman February 20, 2025

RealEcon

Donald Trump Wants Reciprocity in Trade: Here’s a Closer Look
The president’s plan for reciprocal tariffs sounds good in theory. But there was a reason the United States abandoned the approach a century ago. The gains would be few and the costs enormous.

Article by Edward Alden and Jennifer Hillman February 14, 2025 RealEcon

China Strategy Initiative

India, the United States and the Future of the International Trade Order
India has enjoyed bipartisan support in the U.S. as a critical economic counterbalance to China, but the United States still has a tenuous grasp on its interests. In this series, three experts examine India’s position on digital trade, the World Trade Organization (WTO), and industrial policy.

Article by Manjari Chatterjee Miller February 10, 2025 China Strategy Initiative